Cameco's Adjusted EBITDA Surges 44% in Q1 2026, But Execution Risks Remain

What happened

Cameco reported a 44% YoY increase in adjusted EBITDA for Q1 2026, driven by stronger uranium pricing and Westinghouse's contribution. The growth underscores the company's leverage to improving uranium market conditions and its diversified nuclear services platform. However, the DeepValue report highlights that the stock's premium valuation (P/E ~101, EV/EBITDA ~57) leaves little margin for safety. The key near-term risk is the extended Q3 shutdown at Key Lake, which could force costly replacement purchases and pressure cash conversion. For patient investors, the base case implies a fair value of $110, but the wait rating suggests waiting for realized uranium prices to converge toward spot levels and Westinghouse to demonstrate consistent cash distributions.

Implication

Cameco's Q1 results affirm its earnings power from uranium and Westinghouse, but the stock already prices in a significant step-up. The next 6-12 months hinge on execution through the Key Lake shutdown and realized pricing progress. Without proof of cash conversion, the high multiple (P/E 101) makes the stock vulnerable to disappointment. The attractive entry point remains near $90, and we maintain a wait rating with a re-assessment window of 6-12 months. Only if realized uranium prices exceed $72/lb and Westinghouse delivers another $50M+ distribution would the call improve.

Thesis delta

The 44% EBITDA beat is consistent with the base case scenario in our master report and does not alter the thesis. The premium valuation and Key Lake execution risk still argue for patience. No shift; continue to wait for a more attractive entry or confirmation of cash conversion.